Apposite Capital invests in NIMGenetics
Apposite Capital, a private equity firm specialising in healthcare, has made an initial investment of EUR7 million in NIMGenetics, a genetic diagnostic laboratory based in Spain. The company is operating in a fast-growing market and generated 34 per cent in revenue growth last year. Apposite’s investment will enable NIMGenetics